Nvidia Corp. is looking to capitalize on the agentic artificial intelligence trend not only by providing the underlying infrastructure, but also the models that power these next-generation autonomous ...

Massive training datasets are the gateway to powerful AI models — but often, also those models’ downfall. Biases emerge from prejudicial patterns concealed in large datasets, like pictures of mostly ...

What if you could demystify one of the most fantastic technologies of our time—large language models (LLMs)—and build your own from scratch? It might sound like an impossible feat, reserved for elite ...

Last summer could only be described as an “AI summer,” especially with large language models making an explosive entrance. We saw huge neural networks trained on a massive corpora of data that can ...

If we’re ever going to have a just economy, we’ll have to build it from the ground up. Flowing resources to front-line communities that face the worst of the climate crisis and the racial wealth gap ...

Machine learning startup Predibase Inc. today announced the commercial availability of its low-code declarative machine learning platform for artificial intelligence developers, adding new features ...

With the GlobalBuildingAtlas, a research team at the Technical University of Munich (TUM) has created the first high-resolution 3D map of all buildings worldwide. The open data provides a crucial ...

Data development platform Encord is going beyond business analysis to become "the world's only multimodal AI data development platform." To fine-tune an AI model, you need quality -- and sometimes ...

Microbiomes play a key role for plant health and could make agriculture more sustainable -- but the principles behind the assembly of their communities have remained largely unknown. Researchers have ...

The term AI arms race is often taken to mean the competition among a relatively small group of Big Tech companies and well-funded startups to build large generative AI models, such as the GPT-4 model ...

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are ...